|
You are here |
direct.mit.edu | ||
| | | | |
diabetesjournals.org
|
|
| | | | | Five Phase 3 SURPASS trials have shown robust efficacy of novel dual GIP/GLP-1 receptor agonist, tirzepatide, in glycaemic control and body weight (BW) loss in | |
| | | | |
read.dukeupress.edu
|
|
| | | | | ||
| | | | |
ashpublications.org
|
|
| | | | | Advertising in Blood Advances | Blood Advances | American Society of Hematology Advertising in Blood Advances Reach your hematology and hemo-oncology audience, to share your message using our multiple vehicles to communicate directly to the thousands of active medical professionals worldwide. Blood Advances is the open-access, peer-reviewed journal of the American Society of Hematology (ASH). Its circulation extends to clinicians, trainees,... | |
| | | | |
www.newyorker.com
|
|
| | | [AI summary] The article explores the evolving landscape of higher education, touching on issues like the decline of the English paper, the impact of the pandemic on academic practices, debates over curriculum and political activism in schools, and the future of educational technology and policy. | ||